Inflammation and Macular Oedema after Pars Plana Vitrectomy

Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation is known to play a major role in its development. The macula may develop cytotoxic oedema when the primary lesion and flu...

Full description

Saved in:
Bibliographic Details
Main Authors: Vito Romano, Martina Angi, Fabrizio Scotti, Renata del Grosso, Davide Romano, Francesco Semeraro, Paolo Vinciguerra, Ciro Costagliola, Mario R. Romano
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/971758
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation is known to play a major role in its development. The macula may develop cytotoxic oedema when the primary lesion and fluid accumulation occur in the parenchymatous cells (intracellular oedema) or vasogenic oedema when the primary defect occurs in the blood-retinal barrier and leads to extracellular fluid accumulation (extracellular oedema). We report on the mechanisms of CMO formation after pars plana vitrectomy and associated surgical procedures and discuss possible therapeutic approaches.
ISSN:0962-9351
1466-1861